High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis
Authors
Keywords
-
Journal
BLOOD
Volume 124, Issue 10, Pages 1655-1658
Publisher
American Society of Hematology
Online
2014-07-01
DOI
10.1182/blood-2014-05-577361
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The MEK1/2 Inhibitor AS703026 Circumvents Resistance to the BRAF Inhibitor PLX4032 in Human Malignant Melanoma Cells
- (2013) Seong Joon Park et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma
- (2013) F. Catalanotti et al. CLINICAL CANCER RESEARCH
- A prolonged complete response in a patient with BRAF-mutated melanoma stage IV treated with the MEK1/2 inhibitor selumetinib (AZD6244)
- (2012) Marye J. Boers-Sonderen et al. ANTI-CANCER DRUGS
- Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation
- (2012) J. Haroche et al. BLOOD
- BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis
- (2012) F. Sahm et al. BLOOD
- MEK genomics in development and disease
- (2012) J. L. Bromberg-White et al. Briefings in Functional Genomics
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
- (2012) Marcin Imielinski et al. CELL
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma
- (2011) Kim Hookim et al. CANCER CYTOPATHOLOGY
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma
- (2011) Sergey I Nikolaev et al. NATURE GENETICS
- Multisystem Langerhans Cell Histiocytosis in Children
- (2011) Milen Minkov PEDIATRIC DRUGS
- Recurrent BRAF mutations in Langerhans cell histiocytosis
- (2010) G. Badalian-Very et al. BLOOD
- Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors
- (2009) Thierry O. Fischmann et al. BIOCHEMISTRY
- MEK1 mutations confer resistance to MEK and B-RAF inhibition
- (2009) C. M. Emery et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel MEK1 Mutation Identified by Mutational Analysis of Epidermal Growth Factor Receptor Signaling Pathway Genes in Lung Adenocarcinoma
- (2008) J. L. Marks et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started